Table 3.

Therapeutic measures of pH categories ≤ 7.28 and > 7.28.

	pH ≤ 7.28 n (%) or Md (IQR)*	pH > 7.28 n (%) or Md (IQR)*	P-value
Sedation level (RASS)	−4 (−5 - −4)	−4 (−5– −3)	0.01
Inotropic support (hours)	24 (9 - 45)	19 (10 - 36)	0.11
Noradrenaline			< 0.001
> 0.5 µg/kg/min	85 (55.9)	29 (20.4)
< 0.5 µg/kg/min	60 (39.5)	91 (64.1)
Dobutamine			0.12
> 0.5 µg/kg/min	11 (7.2)	3 (2.1)
< 0.5 µg/kg/min	3 (2.0)	2 (1.4)
Milrinone			> 0.20
> 0.25 µg/kg/min	28 (18.3)	19 (13.3)
< 0.25 µg/kg/min	12 (7.8)	10 (7.0)
Adrenaline			> 0.20
> 0.20 µg/kg/min	7 (4.6)	2 (1.4)
< 0.20 µg/kg/min	5 (3.3)	3 (2.1)
Vasopressin/Terlipressin			0.001
> 0.02 units/min	33 (21.6)	11 (7.7)
< 0.02 units/min	18 (11.8)	10 (7.0)
CRRT (default mode CVVHDF) < 36 mL/kg	87 (37.5)	44 (30.8)	> 0.20
CRRT (default mode CVVHDF) > 36 mL/kg	67 (44.4)	21 (14.7)	< 0.001
Bicarbonate infusion			< 0.001
> 42 ng/mL	6 (3.9)	1 (0.7)
6.4 - 42 ng/mL	16 (10.5)	1 (0.7)
< 6.4 ng/mL	7 (4.5)	1 (0.7)
Crystalloids			0.02
> 2000 mL	37 (24.2)	15 (10.5)
1000 – 2000 mL	28 (18.3)	32 (22.4)
<1000 mL	46 (30.1)	46 (32.2)
Red cell	51 (33.3)	31 (21.5)	0.02
Fresh frozen plasma	25 (16.3)	9 (6.3)	0.01
Platelets	21 (13.7)	12 (8.3)	0.14
Albumin			0.18
> 120 g/L	5 (3.3)	2 (1.4)
60 - 120 g/L	15 (9.8)	6 (4.2)
< 60 g/L	22 (14.4)	21 (14.6)

*Values are frequency count (N) and percent (%) for categorical variables or median (Md) and Interquartile range (IQR) for quantitative variables.